Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
appetite & satiety Studied for how amylin and GLP-1 receptor signaling together influence appetite and food intake across preclinical and clinical research
It is widely prescribed for the management of peripheral neuropathy, diabetic neuropathy, and megaloblastic anemia caused by Vitamin B12 deficiency
nominal content per vial as labelled Certificate of Analysis (COA) included with each lot Compliance For laboratory research use only (RUO)
Semaglutide: Linear polypeptide PEPTIDE SEQUENCE Cagrilintide: ?Glu-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH 2 Semaglutide: H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH CHEMICAL STRUCTURE Cagrilintide: Semaglutide: CHEMICAL STRUCTURE Cagrilintide: C 194 H 312 N 54 O 59 S 2 Semaglutide: C 187 H 291 N 45 O 59 Mechanism of Action Cagrilintide acts primarily as a long-acting amylin analogue, stimulating amylin and calcitonin receptors to promote satiety, slow gastric emptying, and suppress postprandial glucagon release
